DSM reports lower sales, earnings on negative currency effects, weakness in caprolactam
06:35 AM | August 5, 2014 | Natasha Alperowicz
DSM today reported second-quarter net profit from continuing operations before exceptional items of €110 million ($147.6 million), 20% down on the year-earlier quarter. Revenues from continuing...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.